Kanamycin Sulfatea

Hazard statements (CLP)

H317, H334, H360FD

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Classification of the substance or mixture

Physical hazards

Based on available data, the classification criteria are not met

Health hazards

Respiratory Sensitization Category 1 (H334) Skin Sensitization Category 1 (H317) Reproductive Toxicity Category 1B (H360FD)

Environmental hazards

Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16

Signal word

Danger

Hazard statements

H317 - May cause an allergic skin reaction H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H360FD - May damage fertility. May damage the unborn child

Precautionary statements

P201 - Obtain special instructions before use P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P308 + P313 - IF exposed or concerned: Get medical advice/attention P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing Additional EU labelling Restricted to professional users

2.3 Other hazards

This product does not contain any known or suspected endocrine disruptors

2.1 Classification of the substance or mixture

CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Physical hazards Based on available data, the classification criteria are not met Health hazards Respiratory Sensitization Category 1 (H334) Skin Sensitization Category 1 (H317) Reproductive Toxicity Category 1B (H360FD) Environmental hazards Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16